FDA Inspection 1106714 — St. Luke's Cancer Institute

St. Luke's Cancer Institute — FEI 3004380123

The FDA completed an inspection of St. Luke's Cancer Institute on September 25, 2019 in Twin Falls, ID. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 25, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Twin Falls, ID (United States)